CAP in Cell Experiments: A Second Key Reference
1. Research Background and Objectives
Cold Atmospheric Plasma (CAP) is a type of plasma generated at room temperature, with potential antibacterial and anti-tumor properties. Acidic Fibroblast Growth Factor (aFGF) is a long-acting cell proliferation factor that can promote the proliferation of various cells. This study combines these two technologies for the first time to explore their synergistic effect in multi-tissue regeneration.
2. Research Methods
3. Experimental Findings
(1) Wound Healing
CAP enhanced wound healing effects by promoting the proliferation of mouse fibroblasts and reducing skin inflammation. aFGF promoted angiogenesis by up-regulating pro-angiogenic markers (such as CD31, VEGF, TGF-ฮฒ) and down-regulating anti-angiogenic proteins (such as angiostatin and angiopoietin-2).
(2) Angiogenesis
The combined effect of CAP and aFGF showed a synergistic effect in angiogenesis. CAP induced fibroblast proliferation by increasing Reactive Oxygen Species (ROS), while aFGF up-regulated pro-angiogenic factors such as VEGF [1].(3) Neurogenesis
(4) Osteogenesis
CAP was superior to aFGF in osteogenesis, showing more significant bone nodule formation.4. Advantages and Potential
(1) Advantages of CAP
(2) Advantages of aFGF
(3) Advantages of Combined Therapy
5. Application Prospects
6. Other Related Studies
(1) Application of Cold Plasma in Burn Treatment
(2) Application of Cold Plasma in Cancer Treatment
(3) Role of Cold Plasma in Skin Regeneration
7. Conclusion
This study combines cold plasma and acidic fibroblast growth factor for the first time, demonstrating their synergistic effect in multi-tissue regeneration. CAP and aFGF show advantages in osteogenesis, neurogenesis, angiogenesis, and other aspects respectively, and the combined therapy can achieve more comprehensive tissue repair. Future research can further explore their applications in different tissues and diseases, as well as conduct in-depth studies on their mechanisms of action.
References
[1] Tan F, Rui X, Xiang X, Yu Z, Al-Rubeai M. Multimodal treatment combining cold atmospheric plasma and acidic fibroblast growth factor for multi-tissue regeneration. FASEB J. 2021;35(6): e21442.
[2] Laroussi M. Cold plasma in medicine and healthcare: the new frontier in low-temperature plasma applications. Front Phys. 2020;8:74.
[3] Branรฝ D, Dvorskรก D, Halaลกovรก E, ล kovierovรก H. Cold atmospheric plasma: a powerful tool for modern medicine. Int J Mol Sci. 2020;21:2932.ย
[4] Tan F, Wang Y, Zhang S, Shui Chen Z, Chen G, Obenchain R, Zhang R, Bai F, Fang T, Gu Z. Cold atmospheric plasma delivery for biomedical applications. Mater Today. 2022;54:153โ88.
[5] Bekeschus S, von Woedtke T, Emmert S, Schmidt A. Medical gas plasma-stimulated wound healing: evidence and mechanisms. Redox Biol. 2021;46: 102116.
[6] Arndt S, Unger P, Berneburg M, Bosserhoff AK, Karrer S. Cold atmospheric plasma (CAP) activates angiogenesis-related molecules in skin keratinocytes, fibroblasts and endothelial cells and improves wound angiogenesis in an autocrine and paracrine mode. J Dermatol Sci. 2018;89:181โ90.
[7] Guo J, Huang Y, Xu B, Yang J. Efficacy of cold atmospheric plasma therapy on chronic wounds: an updated systematic review and meta-analysis of RCTs. Comput Math Methods Med. 2022;2022:5798857.
[8] Duarte S, Panariello BHD. Comprehensive biomedical applications of low-temperature plasmas. Arch Biochem Biophys. 2020;693: 108560.
[9] von Woedtke T, Reuter S, Masur K, Weltmann KD. Plasmas for medicine. Phys Rep. 2013;530:291โ320.
[10] Park GY, Park SJ, Choi MY, Koo IG, Byun JH, Hong JW, Lee JK. Atmospheric-pressure plasma sources for biomedical applications. Plasma Sources Sci Technol. 2012;21: 043001.
[11] Canady J, Murthy SR, Zhuang T, Gitelis S, Nissan A, Ly L, Basadonna G. The first cold atmospheric plasma phase I clinical trial for the treatment of advanced solid tumors: a novel treatment arm for cancer. Cancers. 2023;15:3688.